Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia.

Zhu J, Cui L, Wang W, Hang XY, Xu AX, Yang SX, Dou JT, Mu YM, Zhang X, Gao JP.

Fam Cancer. 2013 Dec;12(4):657-67. doi: 10.1007/s10689-013-9642-y.

PMID:
23754170
2.

Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.

Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, Sasano H, Saito Y.

Clin Endocrinol (Oxf). 2004 Feb;60(2):192-200.

PMID:
14725680
3.

Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.

Gagliardi L, Hotu C, Casey G, Braund WJ, Ling KH, Dodd T, Manavis J, Devitt PG, Cutfield R, Rudzki Z, Scott HS, Torpy DJ.

Clin Endocrinol (Oxf). 2009 Jun;70(6):883-91. doi: 10.1111/j.1365-2265.2008.03471.x. Epub 2008 Nov 5.

PMID:
19018784
4.

Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.

de Miguel V, Redal MA, Viale ML, Kahan M, Glerean M, Beskow A, Fainstein Day P.

Medicina (B Aires). 2010;70(3):254-6.

PMID:
20529775
5.

Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.

Assie G, Louiset E, Sturm N, René-Corail F, Groussin L, Bertherat J, Thomas M, Lefebvre H, Feige JJ, Clauser E, Chabre O, Cherradi N.

J Clin Endocrinol Metab. 2010 Oct;95(10):E253-62. doi: 10.1210/jc.2009-2281. Epub 2010 Jul 21.

PMID:
20660048
6.

Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members.

Nies C, Bartsch DK, Ehlenz K, Wild A, Langer P, Fleischhacker S, Rothmund M.

Exp Clin Endocrinol Diabetes. 2002 Sep;110(6):277-83.

PMID:
12373631
7.

Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.

Vezzosi D, Cartier D, Régnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H, Caron P.

Eur J Endocrinol. 2007 Jan;156(1):21-31.

8.

[ACTH-independent bilateral adrenocortical macronodular hyperplasia (AIMAH): report of a case].

Nakano M, Tada K, Takahashi Y, Deguchi T, Kuriyama M, Ban Y, Kawada Y, Hanafusa J, Morita H, Yasuda K.

Hinyokika Kiyo. 1995 Jul;41(7):529-32. Japanese.

9.

Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.

Lacroix A, Bourdeau I.

Endocrinol Metab Clin North Am. 2005 Jun;34(2):441-58, x. Review.

PMID:
15850852
10.

ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.

Alencar GA, Lerario AM, Nishi MY, Mariani BM, Almeida MQ, Tremblay J, Hamet P, Bourdeau I, Zerbini MC, Pereira MA, Gomes GC, Rocha Mde S, Chambo JL, Lacroix A, Mendonca BB, Fragoso MC.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1501-9. doi: 10.1210/jc.2013-4237. Epub 2014 Apr 7.

PMID:
24708098
11.

ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.

Bourdeau I, Oble S, Magne F, Lévesque I, Cáceres-Gorriti KY, Nolet S, Awadalla P, Tremblay J, Hamet P, Fragoso MC, Lacroix A.

Eur J Endocrinol. 2016 Jan;174(1):85-96. doi: 10.1530/EJE-15-0642.

12.
13.

Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia.

Costa MH, Lacroix A.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1226-37. Review.

14.

Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia.

Zhang Q, Cui L, Gao JP, Yan WH, Jin N, Chen K, Zang L, Du J, Wang XL, Guo QH, Yang GQ, Yang LJ, Ba JM, Gu WJ, Lv ZH, Dou JT, Mu YM, Lu JM.

Endocr J. 2017 Dec 27. doi: 10.1507/endocrj.EJ17-0317. [Epub ahead of print]

15.

Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.

Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ, Chabre O.

Arq Bras Endocrinol Metabol. 2007 Dec;51(9):1452-62.

16.

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.

de Groot JW, Links TP, Themmen AP, Looijenga LH, de Krijger RR, van Koetsveld PM, Hofland J, van den Berg G, Hofland LJ, Feelders RA.

Eur J Endocrinol. 2010 Aug;163(2):293-9. doi: 10.1530/EJE-10-0058. Epub 2010 May 11.

17.

[Cushing's syndrome with bilateral nodular adrenal enlargement].

op den Winkel M, Auernhammer CJ, Jauch KW, Assmann G, Dietz C, Parhofer KG.

Internist (Berl). 2007 Aug;48(8):870-3. German.

PMID:
17605113
18.

Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors.

Christopoulos S, Bourdeau I, Lacroix A.

Horm Res. 2005;64(3):119-31. Review.

19.

Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases.

Lamas C, Alfaro JJ, Lucas T, Lecumberri B, Barceló B, Estrada J.

Eur J Endocrinol. 2002 Feb;146(2):237-40.

20.

Supplemental Content

Support Center